Tralokinumab – anti IL-13 monoclonal antibody for treatment of asthma or idiopathic pulmonary fibrosis

Research output: Contribution to journalLiterature review

Original languageEnglish
Pages (from-to)183-187
Number of pages5
JournalDrugs of the Future
Volume39
Issue number3
DOIs
Publication statusPublished - 2014

Cite this

Tralokinumab – anti IL-13 monoclonal antibody for treatment of asthma or idiopathic pulmonary fibrosis. / Walsh, Garry Michael.

In: Drugs of the Future , Vol. 39, No. 3, 2014, p. 183-187.

Research output: Contribution to journalLiterature review

@article{3fc92e69433e4c8d9a8a753f30c5900a,
title = "Tralokinumab – anti IL-13 monoclonal antibody for treatment of asthma or idiopathic pulmonary fibrosis",
author = "Walsh, {Garry Michael}",
year = "2014",
doi = "10.1358/dof.2014.039.03.2126537",
language = "English",
volume = "39",
pages = "183--187",
journal = "Drugs of the Future",
number = "3",

}

TY - JOUR

T1 - Tralokinumab – anti IL-13 monoclonal antibody for treatment of asthma or idiopathic pulmonary fibrosis

AU - Walsh, Garry Michael

PY - 2014

Y1 - 2014

U2 - 10.1358/dof.2014.039.03.2126537

DO - 10.1358/dof.2014.039.03.2126537

M3 - Literature review

VL - 39

SP - 183

EP - 187

JO - Drugs of the Future

JF - Drugs of the Future

IS - 3

ER -